Addresses whether a group purchasing organization based prescription-drug program operated for the benefit of a group of non-profit schools, colleges, and universities would fall within the Non-Profit Institutions Act (NPIA) exemption to the Robinson-Patman Act
Our staff issue advisory opinions to help clarify FTC rules and decisions regarding either competition or consumer protection issues, often in response to requests from businesses and industry groups. To find a specific opinion, use the filters on this page. Parties may request advice from our staff concerning proposed conduct.
Health Care Antitrust Issues
Re: Follow-Up to February 9, 2002 MedSouth, Inc. Staff Advisory Opinion
re: Proposed settlement of infringement litigation with Teva Pharmaceuticals involving sharing of the exclusivity period for the drug Paraplatin.
re: Transfer of pharmaceuticals at cost by non-profit hospital to patients of non-profit Free Clinic